Form 4: Checkpoint Therapeutics CFO Sells Shares to Cover Tax Obligations

William Garrett Gray, CFO of Checkpoint Therapeutics, sold 12,322 shares of common stock on April 1, 2025, to cover tax withholding obligations related to vesting restricted shares.

Summary

• On April 1, 2025, William Garrett Gray, the Chief Financial Officer of Checkpoint Therapeutics, sold 12,322 shares of common stock.
• The sale was executed at a weighted average price of $4.05 per share, with prices ranging from $4.04 to $4.05.
• The transaction was conducted by the company's restricted stock administrator to satisfy Mr. Gray's tax withholding obligations related to the vesting of restricted shares.
• Mr. Gray had no discretion over the sale, which was automated according to company policy.
• Following the transaction, Mr. Gray beneficially owns 1,446,322 shares, including restricted common stock that vests over time.

Sentiment

Score: 6

Explanation: The document describes a routine transaction (sale of shares to cover taxes). It's neutral from an investment perspective as it doesn't indicate any fundamental change in the company's prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock are a common practice among company executives. This transaction is a routine part of executive compensation and tax management.

Key Dates

Keywords

Checkpoint Therapeutics, CKPT, William Garrett Gray, CFO, stock sale, Form 4, insider trading, restricted stock, tax withholding